We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$33.9B
AUM Growth
-$1.05B
Cap. Flow
-$1.27B
Cap. Flow %
-3.76%
Top 10 Hldgs %
9.76%
Holding
1,528
New
93
Increased
461
Reduced
505
Closed
116

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$50.1M
2
GCO icon
Genesco
GCO
+$46.4M
3
DAN icon
Dana Inc
DAN
+$41.3M
4
KW
Kennedy-Wilson Holdings
KW
+$31.1M
5
JBTM
JBT Marel
JBTM
+$30.8M

Sector Composition

Rank Sector Weight
1 Industrials 23.38%
2 Technology 16.32%
3 Consumer Discretionary 13.09%
4 Financials 9.81%
5 Materials 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMI icon
1026
Marcus & Millichap
MMI
$1.18B
$2.33M 0.01%
+130,660
New +$2.11M
DLIA
1027
DELISTED
DELIA*S INC
DLIA
$2.29M 0.01%
2,732,395
+125,000
+5% +$114K
PLCM
1028
DELISTED
POLYCOM INC
PLCM
$2.26M 0.01%
165,000
AMTD
1029
DELISTED
TD Ameritrade Holding Corp
AMTD
$2.24M 0.01%
66,100
CCRN icon
1030
Cross Country Healthcare
CCRN
$428M
$2.24M 0.01%
277,900
-120,000
-30% -$1.18M
ENVI
1031
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
$2.19M 0.01%
708,000
-165,300
-19% -$586K
GTT
1032
DELISTED
GTT Communications, Inc.
GTT
$2.19M 0.01%
207,660
-5,900
-3% -$59.2K
KMG
1033
DELISTED
KMG Chemicals Inc
KMG
$2.18M 0.01%
139,300
+29,900
+27% +$467K
CBI
1034
DELISTED
Chicago Bridge & Iron Nv
CBI
$2.18M 0.01%
25,000
HDSN
1035
Hudson Technologies
HDSN
$260M
$2.18M 0.01%
777,604
MDSO
1036
DELISTED
Medidata Solutions, Inc.
MDSO
$2.17M 0.01%
40,000
-1,700
-4% -$104K
SNAK
1037
DELISTED
Inventure Foods, Inc.
SNAK
$2.17M 0.01%
155,000
-158,147
-51% -$2.07M
MX icon
1038
Magnachip Semiconductor
MX
$125M
$2.16M 0.01%
155,000
-69,000
-31% -$1.1M
WRN
1039
Western Copper and Gold
WRN
$481M
$2.15M 0.01%
2,212,500
WTM icon
1040
White Mountains Insurance
WTM
$5.48B
$2.12M 0.01%
3,534
RMD icon
1041
ResMed
RMD
$28.9B
$2.09M 0.01%
46,800
QCOR
1042
DELISTED
QUESTCOR PHARMA INC
QCOR
$2.09M 0.01%
32,200
-16,000
-33% -$1.02M
ZGNX
1043
DELISTED
Zogenix, Inc.
ZGNX
$2.09M 0.01%
91,810
-66,450
-42% -$2.16M
SIMG
1044
DELISTED
SILICON IMAGE INC
SIMG
$2.09M 0.01%
302,500
+16,000
+6% +$98.6K
SWKS icon
1045
Skyworks Solutions
SWKS
$8.93B
$2.08M 0.01%
55,500
+3,600
+7% +$118K
GFIG
1046
DELISTED
GFI GROUP INC
GFIG
$2.06M 0.01%
580,000
CHGG icon
1047
Chegg
CHGG
$91.4M
$2.04M 0.01%
291,700
+192,500
+194% +$1.34M
URS
1048
DELISTED
URS CORP
URS
$2.04M 0.01%
43,400
-4,400
-9% -$213K
SENEB
1049
Seneca Foods Class B
SENEB
$1.16B
$2.03M 0.01%
63,202
VRSK icon
1050
Verisk Analytics
VRSK
$26.3B
$2.02M 0.01%
33,598
-21,100
-39% -$1.34M

Similar funds

Royce & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Royce & Associates held 1,528 positions worth $33.9B, down 3% from $34.9B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Royce & Associates withdrew a net $1.27B in Q1 2014, closing 116 positions and reducing 505 holdings. Its most notable exit was ARDEN GROUP INC CL-A, an estimated $34.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Neenah, Inc. Common Stock worth $23.5M.

  • Royce & Associates's largest Q1 2014 buy was Neenah, Inc. Common Stock: 454,500 shares worth $23.5M.
  • Royce & Associates added most to Medicines Co in Q1 2014, an estimated $50.1M increase.
  • Royce & Associates's biggest Q1 2014 reduction was TOWERS WATSON & CO COM STK CL A (DE), cutting an estimated $87.3M.
  • Royce & Associates fully exited ARDEN GROUP INC CL-A in Q1 2014, selling an estimated $34.3M.
  • Royce & Associates's ten largest holdings make up 9.8% of its $33.9B portfolio in Q1 2014.
  • Royce & Associates opened 93 new positions and closed 116 in Q1 2014.
  • Royce & Associates's portfolio value fell 3% quarter-over-quarter to $33.9B.

Based on Royce & Associates's 13F filing for Q1 2014, filed 12 May 2014.